{{Rsnum
|rsid=12184413
|Gene=MMP7
|Chromosome=11
|position=102518857
|Orientation=plus
|GMAF=0.1354
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 81.2 | 17.2 | 1.6
| HCB | 46.3 | 46.3 | 7.3
| JPT | 61.0 | 39.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 46.3 | 46.3 | 7.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|18648013|OA=1
}} [[rs12184413]](T;T) was associated with reduced risk for [[breast cancer]], with an odds ratio of 0.7 (CI: 0.6-0.9), based on a study ultimately totaling over 3,000 cases (and an equal number of controls).

{{PMID|18798254|OA=1
}} Genetic polymorphisms in the MMP-7 gene and breast cancer survival.

{{PMID|19435861|OA=1
}} No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}